Evidence map›Paper›PMID 39464154›Full record

ArticlebioRxiv : the preprint server for biology2025

STRAIGHT-IN Dual: a platform for dual, single-copy integrations of DNA payloads and gene circuits into human induced pluripotent stem cell.

Albert Blanch-Asensio, Deon S Ploessl, Sara Cascione, Benjamin B Johnson, Myrthe R M Berndsen, Nathan B Wang, Valeria Orlova, Anna Alemany, Christine L Mummery, Kate E Galloway and 1 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Albert Blanch-AsensioDepartment of Anatomy and Embryology, Leiden University Medical Center, 2300RC Leiden, The Netherlands.ORCID 0000-0001-5608-220X
Deon S PloesslDepartment of Chemical Engineering, Massachusetts Institute of Technology, MA 02139 Cambridge, USA.ORCID 0000-0002-5033-2068
Sara CascioneDepartment of Anatomy and Embryology, Leiden University Medical Center, 2300RC Leiden, The Netherlands.ORCID 0000-0003-2573-7263
Benjamin B JohnsonDepartment of Anatomy and Embryology, Leiden University Medical Center, 2300RC Leiden, The Netherlands.ORCID 0000-0002-6280-8385
Myrthe R M BerndsenDepartment of Anatomy and Embryology, Leiden University Medical Center, 2300RC Leiden, The Netherlands.ORCID 0009-0002-3217-5676
Nathan B WangDepartment of Chemical Engineering, Massachusetts Institute of Technology, MA 02139 Cambridge, USA.ORCID 0000-0002-9507-6475
Valeria OrlovaDepartment of Anatomy and Embryology, Leiden University Medical Center, 2300RC Leiden, The Netherlands.ORCID 0000-0002-1169-2802
Anna AlemanyDepartment of Anatomy and Embryology, Leiden University Medical Center, 2300RC Leiden, The Netherlands.ORCID 0000-0002-0795-0290
Christine L MummeryDepartment of Anatomy and Embryology, Leiden University Medical Center, 2300RC Leiden, The Netherlands.ORCID 0000-0002-4549-6535
Kate E GallowayDepartment of Chemical Engineering, Massachusetts Institute of Technology, MA 02139 Cambridge, USA.ORCID 0000-0001-7416-3193
Richard P DavisDepartment of Anatomy and Embryology, Leiden University Medical Center, 2300RC Leiden, The Netherlands.ORCID 0000-0002-7917-9423

Funding

Multiscale tools and approaches for understanding and engineering cell-fate transitionsR35GM143033 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GALLOWAY, KATE ELIZABETH · 2021 to 2025
$1.9M
NIGMS NIH HHS R35 GM143033
6 · The paper itself

Abstract

Targeting DNA payloads into human (h)iPSCs involves multiple time-consuming, inefficient steps that must be repeated for each construct. Here, we present STRAIGHT-IN Dual, which enables simultaneous, allele-specific, single-copy integration of two DNA payloads with 100% efficiency within one week. Notably, STRAIGHT-IN Dual leverages the STRAIGHT-IN platform to allow near-scarless cargo integration, facilitating the recycling of components for subsequent cellular modifications. Using STRAIGHT-IN Dual, we investigated how promoter choice and gene syntax influence transgene silencing, demonstrating the impact these design features have on reporter gene expression and forward programming of hiPSCs into neurons, motor neurons, and endothelial cells. Furthermore, we designed a grazoprevir-inducible synZiFTR system to complement the widely used tetracycline-inducible system, providing independent, tunable, and temporally controlled expression of different transcription factors within the same cell. The unprecedented efficiency and speed with which STRAIGHT-IN Dual generates homogenous genetically engineered hiPSC populations represents a major advancement for synthetic biology in stem cell applications and opens opportunities for precision cell engineering.

Identifiers

PMID39464154
PMCPMC11507887

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.